These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 35525236)

  • 41. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
    Lee FK; Wong AK; Lee YW; Wan OW; Chan HY; Chung KK
    J Neurochem; 2009 Jul; 110(1):208-19. PubMed ID: 19457126
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monoamine Oxidase-B Inhibition Facilitates α-Synuclein Secretion
    Nakamura Y; Arawaka S; Sato H; Sasaki A; Shigekiyo T; Takahata K; Tsunekawa H; Kato T
    J Neurosci; 2021 Sep; 41(35):7479-7491. PubMed ID: 34290084
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autophagy-dependent removal of α-synuclein: a novel mechanism of GM1 ganglioside neuroprotection against Parkinson's disease.
    Guo YL; Duan WJ; Lu DH; Ma XH; Li XX; Li Z; Bi W; Kurihara H; Liu HZ; Li YF; He RR
    Acta Pharmacol Sin; 2021 Apr; 42(4):518-528. PubMed ID: 32724177
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exosome-mediated delivery of antisense oligonucleotides targeting α-synuclein ameliorates the pathology in a mouse model of Parkinson's disease.
    Yang J; Luo S; Zhang J; Yu T; Fu Z; Zheng Y; Xu X; Liu C; Fan M; Zhang Z
    Neurobiol Dis; 2021 Jan; 148():105218. PubMed ID: 33296726
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Measurement of proteasomal dysfunction in cell models of dopaminergic degeneration.
    Sun F; Kanthasamy AG; Kanthasamy A
    Methods Mol Biol; 2011; 758():293-305. PubMed ID: 21815074
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuroprotective effects of extract of Acanthopanax senticosus harms on SH-SY5Y cells overexpressing wild-type or A53T mutant α-synuclein.
    Li XZ; Zhang SN; Wang KX; Liu HY; Yang ZM; Liu SM; Lu F
    Phytomedicine; 2014 Apr; 21(5):704-11. PubMed ID: 24252343
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proteasome inhibition and aggregation in Parkinson's disease: a comparative study in untransfected and transfected cells.
    Biasini E; Fioriti L; Ceglia I; Invernizzi R; Bertoli A; Chiesa R; Forloni G
    J Neurochem; 2004 Feb; 88(3):545-53. PubMed ID: 14720204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Parkinson disease-associated A30P mutation stabilizes alpha-synuclein against proteasomal degradation triggered by heme oxygenase-1 over-expression in human neuroblastoma cells.
    Song W; Patel A; Qureshi HY; Han D; Schipper HM; Paudel HK
    J Neurochem; 2009 Jul; 110(2):719-33. PubMed ID: 19457084
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proteasome impairment by α-synuclein.
    Zondler L; Kostka M; Garidel P; Heinzelmann U; Hengerer B; Mayer B; Weishaupt JH; Gillardon F; Danzer KM
    PLoS One; 2017; 12(9):e0184040. PubMed ID: 28945746
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
    Sharma N; Rao SP; Kalivendi SV
    Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A calcineurin- and NFAT-dependent pathway is involved in α-synuclein-induced degeneration of midbrain dopaminergic neurons.
    Luo J; Sun L; Lin X; Liu G; Yu J; Parisiadou L; Xie C; Ding J; Cai H
    Hum Mol Genet; 2014 Dec; 23(24):6567-74. PubMed ID: 25051958
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Authentically phosphorylated α-synuclein at Ser129 accelerates neurodegeneration in a rat model of familial Parkinson's disease.
    Sato H; Arawaka S; Hara S; Fukushima S; Koga K; Koyama S; Kato T
    J Neurosci; 2011 Nov; 31(46):16884-94. PubMed ID: 22090514
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of histone deacetylase, the ubiquitin proteasome system, and autophagy underlies the neuroprotective effects of venlafaxine in a rotenone-induced Parkinson's disease model in rats.
    El-Saiy KA; Sayed RH; El-Sahar AE; Kandil EA
    Chem Biol Interact; 2022 Feb; 354():109841. PubMed ID: 35104487
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of Protein Ubiquitination by Paraquat and 1-Methyl-4-Phenylpyridinium Impairs Ubiquitin-Dependent Protein Degradation Pathways.
    Navarro-Yepes J; Anandhan A; Bradley E; Bohovych I; Yarabe B; de Jong A; Ovaa H; Zhou Y; Khalimonchuk O; Quintanilla-Vega B; Franco R
    Mol Neurobiol; 2016 Oct; 53(8):5229-51. PubMed ID: 26409479
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice.
    Lee MK; Stirling W; Xu Y; Xu X; Qui D; Mandir AS; Dawson TM; Copeland NG; Jenkins NA; Price DL
    Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8968-73. PubMed ID: 12084935
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Silencing of Glucocerebrosidase Gene in
    Abul Khair SB; Dhanushkodi NR; Ardah MT; Chen W; Yang Y; Haque ME
    Front Neurosci; 2018; 12():81. PubMed ID: 29503608
    [No Abstract]   [Full Text] [Related]  

  • 57. cAMP-induced phosphorylation of 26S proteasomes on Rpn6/PSMD11 enhances their activity and the degradation of misfolded proteins.
    Lokireddy S; Kukushkin NV; Goldberg AL
    Proc Natl Acad Sci U S A; 2015 Dec; 112(52):E7176-85. PubMed ID: 26669444
    [TBL] [Abstract][Full Text] [Related]  

  • 58. AMPK-dependent autophagy activation and alpha-Synuclein clearance: a putative mechanism behind alpha-mangostin's neuroprotection in a rotenone-induced mouse model of Parkinson's disease.
    Parekh P; Sharma N; Sharma M; Gadepalli A; Sayyed AA; Chatterjee S; Kate A; Khairnar A
    Metab Brain Dis; 2022 Dec; 37(8):2853-2870. PubMed ID: 36178640
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Usp14 deficiency removes α-synuclein by regulating S100A8/A9 in Parkinson's disease.
    Ding L; Lu L; Zheng S; Zhang Z; Huang X; Ma R; Zhang M; Xu Z; Chen M; Guo Z; Zhu S; Gong J; Mao H; Zhang W; Xu P
    Cell Mol Life Sci; 2024 May; 81(1):232. PubMed ID: 38780644
    [TBL] [Abstract][Full Text] [Related]  

  • 60. p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease.
    Chen J; Mao K; Yu H; Wen Y; She H; Zhang H; Liu L; Li M; Li W; Zou F
    J Neuroinflammation; 2021 Dec; 18(1):295. PubMed ID: 34930303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.